OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies
Laure Gossec, Josef S Smolen, C. Gaujoux-Viala, et al.
Annals of the Rheumatic Diseases (2011) Vol. 71, Iss. 1, pp. 4-12
Open Access | Times Cited: 452
Laure Gossec, Josef S Smolen, C. Gaujoux-Viala, et al.
Annals of the Rheumatic Diseases (2011) Vol. 71, Iss. 1, pp. 4-12
Open Access | Times Cited: 452
Showing 1-25 of 452 citing articles:
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update
Laure Gossec, Josef S Smolen, Sofía Ramiro, et al.
Annals of the Rheumatic Diseases (2015) Vol. 75, Iss. 3, pp. 499-510
Open Access | Times Cited: 885
Laure Gossec, Josef S Smolen, Sofía Ramiro, et al.
Annals of the Rheumatic Diseases (2015) Vol. 75, Iss. 3, pp. 499-510
Open Access | Times Cited: 885
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 6, pp. 700.1-712
Open Access | Times Cited: 828
Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 6, pp. 700.1-712
Open Access | Times Cited: 828
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
Iain B. McInnes, Arthur Kavanaugh, Alice B. Gottlieb, et al.
The Lancet (2013) Vol. 382, Iss. 9894, pp. 780-789
Closed Access | Times Cited: 766
Iain B. McInnes, Arthur Kavanaugh, Alice B. Gottlieb, et al.
The Lancet (2013) Vol. 382, Iss. 9894, pp. 780-789
Closed Access | Times Cited: 766
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
Philip J. Mease, Iain B. McInnes, Bruce Kirkham, et al.
New England Journal of Medicine (2015) Vol. 373, Iss. 14, pp. 1329-1339
Open Access | Times Cited: 683
Philip J. Mease, Iain B. McInnes, Bruce Kirkham, et al.
New England Journal of Medicine (2015) Vol. 373, Iss. 14, pp. 1329-1339
Open Access | Times Cited: 683
Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial
Laura C. Coates, Anna R. Moverley, Lucy McParland, et al.
The Lancet (2015) Vol. 386, Iss. 10012, pp. 2489-2498
Open Access | Times Cited: 446
Laura C. Coates, Anna R. Moverley, Lucy McParland, et al.
The Lancet (2015) Vol. 386, Iss. 10012, pp. 2489-2498
Open Access | Times Cited: 446
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
Josef S Smolen, J. Braun, Maxime Dougados, et al.
Annals of the Rheumatic Diseases (2013) Vol. 73, Iss. 1, pp. 6-16
Open Access | Times Cited: 429
Josef S Smolen, J. Braun, Maxime Dougados, et al.
Annals of the Rheumatic Diseases (2013) Vol. 73, Iss. 1, pp. 6-16
Open Access | Times Cited: 429
Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor
Arthur Kavanaugh, Philip J. Mease, Juan J. Gómez‐Reino, et al.
Annals of the Rheumatic Diseases (2014) Vol. 73, Iss. 6, pp. 1020-1026
Open Access | Times Cited: 423
Arthur Kavanaugh, Philip J. Mease, Juan J. Gómez‐Reino, et al.
Annals of the Rheumatic Diseases (2014) Vol. 73, Iss. 6, pp. 1020-1026
Open Access | Times Cited: 423
A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative
Laure Gossec, Maarten de Wit, Uta Kiltz, et al.
Annals of the Rheumatic Diseases (2014) Vol. 73, Iss. 6, pp. 1012-1019
Open Access | Times Cited: 375
Laure Gossec, Maarten de Wit, Uta Kiltz, et al.
Annals of the Rheumatic Diseases (2014) Vol. 73, Iss. 6, pp. 1012-1019
Open Access | Times Cited: 375
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial
Iain B. McInnes, Joachim Sieper, J. Braun, et al.
Annals of the Rheumatic Diseases (2013) Vol. 73, Iss. 2, pp. 349-356
Open Access | Times Cited: 335
Iain B. McInnes, Joachim Sieper, J. Braun, et al.
Annals of the Rheumatic Diseases (2013) Vol. 73, Iss. 2, pp. 349-356
Open Access | Times Cited: 335
2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative
Christian Dejaco, Yogesh Preet Singh, Pablo Perel, et al.
Arthritis & Rheumatology (2015) Vol. 67, Iss. 10, pp. 2569-2580
Open Access | Times Cited: 271
Christian Dejaco, Yogesh Preet Singh, Pablo Perel, et al.
Arthritis & Rheumatology (2015) Vol. 67, Iss. 10, pp. 2569-2580
Open Access | Times Cited: 271
2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative
Christian Dejaco, Yogesh Preet Singh, Pablo Perel, et al.
Annals of the Rheumatic Diseases (2015) Vol. 74, Iss. 10, pp. 1799-1807
Open Access | Times Cited: 267
Christian Dejaco, Yogesh Preet Singh, Pablo Perel, et al.
Annals of the Rheumatic Diseases (2015) Vol. 74, Iss. 10, pp. 1799-1807
Open Access | Times Cited: 267
A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis
Zoe Ash, C. Gaujoux-Viala, Laure Gossec, et al.
Annals of the Rheumatic Diseases (2011) Vol. 71, Iss. 3, pp. 319-326
Open Access | Times Cited: 257
Zoe Ash, C. Gaujoux-Viala, Laure Gossec, et al.
Annals of the Rheumatic Diseases (2011) Vol. 71, Iss. 3, pp. 319-326
Open Access | Times Cited: 257
Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis
Philip J. Mease, April W. Armstrong
Drugs (2014) Vol. 74, Iss. 4, pp. 423-441
Open Access | Times Cited: 247
Philip J. Mease, April W. Armstrong
Drugs (2014) Vol. 74, Iss. 4, pp. 423-441
Open Access | Times Cited: 247
Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP
Hideki Fujita, Tadashi Terui, Koremasa Hayama, et al.
The Journal of Dermatology (2018) Vol. 45, Iss. 11, pp. 1235-1270
Open Access | Times Cited: 212
Hideki Fujita, Tadashi Terui, Koremasa Hayama, et al.
The Journal of Dermatology (2018) Vol. 45, Iss. 11, pp. 1235-1270
Open Access | Times Cited: 212
A Phase III, Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis: Results of the PALACE 2 Trial
Maurizio Cutolo, Gary E. Myerson, Roy Fleischmann, et al.
The Journal of Rheumatology (2016) Vol. 43, Iss. 9, pp. 1724-1734
Closed Access | Times Cited: 198
Maurizio Cutolo, Gary E. Myerson, Roy Fleischmann, et al.
The Journal of Rheumatology (2016) Vol. 43, Iss. 9, pp. 1724-1734
Closed Access | Times Cited: 198
French guidelines on the use of systemic treatments for moderate‐to‐severe psoriasis in adults
F. Amatore, A. Villani, M. Tauber, et al.
Journal of the European Academy of Dermatology and Venereology (2019) Vol. 33, Iss. 3, pp. 464-483
Open Access | Times Cited: 188
F. Amatore, A. Villani, M. Tauber, et al.
Journal of the European Academy of Dermatology and Venereology (2019) Vol. 33, Iss. 3, pp. 464-483
Open Access | Times Cited: 188
Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis
Andreas Kerschbaumer, Josef S Smolen, Maxime Dougados, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 6, pp. 778-786
Open Access | Times Cited: 169
Andreas Kerschbaumer, Josef S Smolen, Maxime Dougados, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 6, pp. 778-786
Open Access | Times Cited: 169
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations
Alexander Nast, Catherine Smith, Phyllis I. Spuls, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 35, Iss. 2, pp. 281-317
Open Access | Times Cited: 142
Alexander Nast, Catherine Smith, Phyllis I. Spuls, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 35, Iss. 2, pp. 281-317
Open Access | Times Cited: 142
Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis
Andreas Kerschbaumer, Josef S Smolen, Ricardo J O Ferreira, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 6, pp. 760-774
Open Access | Times Cited: 16
Andreas Kerschbaumer, Josef S Smolen, Ricardo J O Ferreira, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 6, pp. 760-774
Open Access | Times Cited: 16
Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study
Asta Baranauskaitė, Helena Raffayová, Nikolay V. Kungurov, et al.
Annals of the Rheumatic Diseases (2011) Vol. 71, Iss. 4, pp. 541-548
Open Access | Times Cited: 192
Asta Baranauskaitė, Helena Raffayová, Nikolay V. Kungurov, et al.
Annals of the Rheumatic Diseases (2011) Vol. 71, Iss. 4, pp. 541-548
Open Access | Times Cited: 192
Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy: Results from the Danish Nationwide DANBIO Registry
Bente Glintborg, Mikkel Østergaard, Niels Steen Krogh, et al.
Arthritis & Rheumatism (2013) Vol. 65, Iss. 5, pp. 1213-1223
Closed Access | Times Cited: 184
Bente Glintborg, Mikkel Østergaard, Niels Steen Krogh, et al.
Arthritis & Rheumatism (2013) Vol. 65, Iss. 5, pp. 1213-1223
Closed Access | Times Cited: 184
Therapies for peripheral joint disease in psoriatic arthritis. A systematic review.
María Laura Acosta Felquer, Laura C. Coates, Enrique R. Soriano, et al.
The Journal of Rheumatology (2006) Vol. 33, Iss. 7, pp. 1422-30
Open Access | Times Cited: 184
María Laura Acosta Felquer, Laura C. Coates, Enrique R. Soriano, et al.
The Journal of Rheumatology (2006) Vol. 33, Iss. 7, pp. 1422-30
Open Access | Times Cited: 184
The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study
K. M. Fagerli, Elisabeth Lie, Désirée van der Heijde, et al.
Annals of the Rheumatic Diseases (2013) Vol. 73, Iss. 1, pp. 132-137
Closed Access | Times Cited: 179
K. M. Fagerli, Elisabeth Lie, Désirée van der Heijde, et al.
Annals of the Rheumatic Diseases (2013) Vol. 73, Iss. 1, pp. 132-137
Closed Access | Times Cited: 179
Review: Nonradiographic axial spondyloarthritis: New definition of an old disease?
Joachim Sieper, Désirée van der Heijde
Arthritis & Rheumatism (2012) Vol. 65, Iss. 3, pp. 543-551
Closed Access | Times Cited: 177
Joachim Sieper, Désirée van der Heijde
Arthritis & Rheumatism (2012) Vol. 65, Iss. 3, pp. 543-551
Closed Access | Times Cited: 177
Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry
Jan Sørensen, Merete Lund Hetland
Annals of the Rheumatic Diseases (2014) Vol. 74, Iss. 3, pp. e12-e12
Open Access | Times Cited: 166
Jan Sørensen, Merete Lund Hetland
Annals of the Rheumatic Diseases (2014) Vol. 74, Iss. 3, pp. e12-e12
Open Access | Times Cited: 166
